Aquestive Therapeutics, Inc. Balance Sheet
AQST|8 years of annual SEC 10-K data (FY2018-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 8 fiscal years. All figures from audited SEC 10-K filings.
Aquestive Therapeutics, Inc. had $160M in total assets with negative shareholders' equity of $34M as of FY2025. Total debt stood at $45M as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | - | - | - | - | - | $31.8M | $49.3M | $60.6M |
| Inventory | $6.2M | $6.0M | $6.8M | $5.8M | $4.0M | $2.5M | $2.9M | $5.4M |
| Current Assets | $149.3M | $88.2M | $41.0M | $39.9M | $47.3M | $44.6M | $68.3M | $74.2M |
| PP&E (Net) | $3.9M | $3.8M | $4.2M | $4.1M | $5.1M | $6.9M | $9.7M | $12.2M |
| Total Assets | $160.4M | $101.4M | $57.4M | $57.1M | $62.0M | $62.9M | $78.5M | $86.9M |
| Current Liabilities | $47.6M | $18.9M | $18.3M | $39.5M | $22.0M | $21.1M | $18.6M | $33.0M |
| Total Debt | $45.0M | $45.0M | $45.0M | - | - | - | - | - |
| Shareholders' Equity | -$33.7M | -$60.2M | -$106.5M | -$118.6M | -$48.5M | -$6.1M | $10.1M | -$68.6M |